Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha2-adrenoceptor agonists.

Robert D Sanders1, Mervyn Maze

  • 1Department of Anaesthetics, Intensive Care and Pain Medicine, Imperial College, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.

Current Opinion in Investigational Drugs (London, England : 2000)
|February 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic β<sub>2</sub>-adrenergic receptor expression.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

One-Year Brain Structural Changes Are Associated with Postoperative Delirium and Delayed Resolution of Interleukin-6.

medRxiv : the preprint server for health sciences·2026
Same author

Responsibility cannot be abdicated: a mandate for patient-centred precision care in perioperative brain health. Comment on Br J Anaesth 2026; 137: 26-30.

British journal of anaesthesia·2026
Same author

C1q-mediated synapse loss by microglial phagocytosis is associated with postoperative neurocognitive disorder in mice.

British journal of anaesthesia·2026
Same author

A novel circuit driven by hypothalamic corticotropin-releasing hormone neurons mediates postoperative memory deficits.

Brain, behavior, and immunity·2026
Same author

Astrocyte-neurone crosstalk mediates dexmedetomidine sedation.

British journal of anaesthesia·2026
Same journal

Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

Current opinion in investigational drugs (London, England : 2000)·2011
Same journal

Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

Current opinion in investigational drugs (London, England : 2000)·2010
Same journal

Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

Current opinion in investigational drugs (London, England : 2000)·2010
See all related articles

Alpha2-adrenoceptor agonists are increasingly used in critical care for sedation and pain relief. Their protective effects on organs and cognition show promise but need more research.

Area of Science:

  • Anesthesiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Alpha2-adrenoceptor agonists are versatile drugs with established roles in medicine.
  • Their use in peri-operative and critical care settings is expanding.
  • These agents are administered to diverse patient populations.

Purpose of the Study:

  • To highlight the growing applications of alpha2-adrenoceptor agonists.
  • To discuss their potential benefits beyond traditional uses.
  • To emphasize the need for further investigation into their protective capabilities.

Main Methods:

  • Literature review of studies on alpha2-adrenoceptor agonists.
  • Analysis of clinical applications in peri-operative and critical care.
  • Synthesis of evidence regarding organ protection and neurocognition.

Related Experiment Videos

Main Results:

  • Alpha2-adrenoceptor agonists are increasingly utilized as premedicants, analgesics, and sedatives.
  • Emerging evidence suggests potential renal, cardiac, and neurocognitive protective effects.
  • These benefits are observed across a wide spectrum of patients.

Conclusions:

  • Alpha2-adrenoceptor agonists offer significant utility in peri-operative and critical care.
  • Their organ-protective and neurocognitive benefits warrant further dedicated research.
  • Continued study is essential to fully understand and leverage these pharmacological properties.